100 likes | 285 Views
Ovarian Carcinoma. Dr Khalid Sait FRCSC Consultant Obstetrics and Gynecology and Gynecological oncology. Evaluation of Ovarian Mass. Preoperative assessment: History Physical Examination Tumour markers Ultrasound Intra-operative assessment.
E N D
Ovarian Carcinoma Dr Khalid Sait FRCSC Consultant Obstetrics and Gynecology and Gynecological oncology
Evaluation of Ovarian Mass • Preoperative assessment: History Physical Examination Tumour markers Ultrasound • Intra-operative assessment
GuidelineEORTIC, NCCN, NIH, SGO • The more localized the disease appear , the more extensive the assessment should be( STAGING) Level II-3 A • Optimal debulking for advance stage provide a median survival benefit Level II-b
Endodermal sinus tumor • Secrete AFP
Chemotherapy. BEP • Cisplatin : 100mg/m i.v d1 • Bleomycin : 10-15mg d1-3(24h inf) • Etoposide : 100mg/m i.v d1-3
SEX CORD-STROMAL TUMORS • SCTS are 15% of all malignant ovarian neoplasm • Hormonal secreting